| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anal Canal | 3 | 2024 | 36 | 1.640 |
Why?
|
| Receptors, G-Protein-Coupled | 4 | 2024 | 127 | 1.460 |
Why?
|
| Muscle Contraction | 7 | 2024 | 202 | 1.400 |
Why?
|
| Muscle, Smooth | 7 | 2024 | 134 | 1.360 |
Why?
|
| Anoctamin-1 | 5 | 2024 | 16 | 1.340 |
Why?
|
| Myocytes, Smooth Muscle | 4 | 2024 | 60 | 1.070 |
Why?
|
| Taste | 2 | 2024 | 36 | 0.900 |
Why?
|
| Regeneration | 6 | 2017 | 94 | 0.870 |
Why?
|
| Taste Buds | 1 | 2024 | 4 | 0.860 |
Why?
|
| Calcium Signaling | 3 | 2021 | 158 | 0.800 |
Why?
|
| Bacillus subtilis | 3 | 2006 | 31 | 0.730 |
Why?
|
| Muscle Relaxation | 1 | 2021 | 32 | 0.690 |
Why?
|
| Gene Deletion | 2 | 2021 | 308 | 0.670 |
Why?
|
| Calcium | 4 | 2024 | 573 | 0.630 |
Why?
|
| Tendons | 3 | 2015 | 26 | 0.580 |
Why?
|
| Glycoside Hydrolases | 2 | 2008 | 5 | 0.550 |
Why?
|
| Osteoarthritis | 3 | 2016 | 142 | 0.540 |
Why?
|
| Tissue Engineering | 4 | 2017 | 140 | 0.490 |
Why?
|
| RNA, Small Interfering | 2 | 2013 | 919 | 0.490 |
Why?
|
| Animals | 23 | 2024 | 20612 | 0.470 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2015 | 37 | 0.450 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2015 | 39 | 0.450 |
Why?
|
| Mice | 14 | 2024 | 10815 | 0.450 |
Why?
|
| Patellar Ligament | 1 | 2013 | 6 | 0.400 |
Why?
|
| Decorin | 1 | 2013 | 3 | 0.400 |
Why?
|
| Lentivirus | 1 | 2013 | 66 | 0.390 |
Why?
|
| Achilles Tendon | 3 | 2017 | 7 | 0.380 |
Why?
|
| Tendon Injuries | 2 | 2014 | 19 | 0.380 |
Why?
|
| Uterine Contraction | 2 | 2024 | 10 | 0.370 |
Why?
|
| Collagen Type V | 1 | 2011 | 2 | 0.360 |
Why?
|
| Stem Cells | 4 | 2017 | 257 | 0.350 |
Why?
|
| Obstetric Labor, Premature | 2 | 2024 | 31 | 0.350 |
Why?
|
| Bacillus | 2 | 2008 | 13 | 0.330 |
Why?
|
| Signal Transduction | 5 | 2019 | 3032 | 0.330 |
Why?
|
| Spinal Cord Injuries | 3 | 2015 | 50 | 0.320 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2017 | 619 | 0.300 |
Why?
|
| Calcium Channels | 2 | 2019 | 103 | 0.280 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 2 | 2019 | 44 | 0.280 |
Why?
|
| Protein Engineering | 1 | 2008 | 82 | 0.280 |
Why?
|
| Rats | 7 | 2017 | 1977 | 0.260 |
Why?
|
| Chondrocytes | 3 | 2016 | 42 | 0.250 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 3 | 2016 | 125 | 0.250 |
Why?
|
| Archaeal Proteins | 1 | 2005 | 6 | 0.240 |
Why?
|
| Archaea | 1 | 2005 | 9 | 0.240 |
Why?
|
| Cell Differentiation | 5 | 2017 | 1347 | 0.230 |
Why?
|
| Tissue Scaffolds | 2 | 2017 | 84 | 0.230 |
Why?
|
| Enzymes | 1 | 2005 | 35 | 0.230 |
Why?
|
| Biotechnology | 1 | 2005 | 43 | 0.230 |
Why?
|
| Gene Expression Regulation | 6 | 2019 | 1616 | 0.230 |
Why?
|
| Gene Expression Profiling | 3 | 2021 | 771 | 0.220 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2015 | 489 | 0.220 |
Why?
|
| Peptides | 1 | 2008 | 574 | 0.220 |
Why?
|
| Calcinosis | 2 | 2016 | 84 | 0.220 |
Why?
|
| Genitalia | 1 | 2024 | 9 | 0.220 |
Why?
|
| Bacterial Proteins | 2 | 2008 | 766 | 0.220 |
Why?
|
| Semen | 1 | 2024 | 48 | 0.210 |
Why?
|
| Water Microbiology | 3 | 2013 | 14 | 0.200 |
Why?
|
| Cartilage, Articular | 2 | 2014 | 78 | 0.200 |
Why?
|
| Homeodomain Proteins | 2 | 2015 | 266 | 0.200 |
Why?
|
| Wound Healing | 2 | 2014 | 189 | 0.200 |
Why?
|
| Base Sequence | 2 | 2021 | 1329 | 0.200 |
Why?
|
| Chlorine | 2 | 2013 | 5 | 0.200 |
Why?
|
| Recombinant Proteins | 1 | 2004 | 701 | 0.190 |
Why?
|
| Drinking Water | 2 | 2013 | 21 | 0.190 |
Why?
|
| Myometrium | 2 | 2024 | 15 | 0.190 |
Why?
|
| Mycobacterium | 2 | 2013 | 38 | 0.190 |
Why?
|
| Cell Lineage | 3 | 2017 | 268 | 0.180 |
Why?
|
| Methacholine Chloride | 1 | 2021 | 23 | 0.180 |
Why?
|
| Tongue | 1 | 2021 | 15 | 0.180 |
Why?
|
| Extracellular Matrix | 2 | 2013 | 139 | 0.180 |
Why?
|
| Water Supply | 2 | 2012 | 15 | 0.170 |
Why?
|
| Reflex | 1 | 2021 | 27 | 0.170 |
Why?
|
| Mice, Knockout | 3 | 2021 | 2107 | 0.170 |
Why?
|
| Respiratory System | 1 | 2021 | 45 | 0.170 |
Why?
|
| Chloride Channels | 2 | 2019 | 28 | 0.160 |
Why?
|
| Nitric Oxide | 1 | 2021 | 174 | 0.160 |
Why?
|
| Humans | 20 | 2024 | 63307 | 0.160 |
Why?
|
| Ligands | 1 | 2021 | 416 | 0.160 |
Why?
|
| Muscle Tonus | 1 | 2019 | 3 | 0.160 |
Why?
|
| Urethra | 1 | 2019 | 75 | 0.150 |
Why?
|
| Viral Tropism | 1 | 2019 | 51 | 0.150 |
Why?
|
| Cytomegalovirus | 1 | 2019 | 91 | 0.140 |
Why?
|
| Disinfectants | 3 | 2013 | 26 | 0.140 |
Why?
|
| Tenocytes | 1 | 2017 | 1 | 0.140 |
Why?
|
| Multiprotein Complexes | 1 | 2019 | 153 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2017 | 52 | 0.140 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2017 | 25 | 0.140 |
Why?
|
| Silk | 1 | 2017 | 7 | 0.140 |
Why?
|
| Xylans | 2 | 2008 | 5 | 0.140 |
Why?
|
| Sulfonic Acids | 1 | 2017 | 8 | 0.140 |
Why?
|
| Gelatin | 1 | 2017 | 29 | 0.140 |
Why?
|
| Chitosan | 2 | 2015 | 85 | 0.130 |
Why?
|
| Printing, Three-Dimensional | 1 | 2017 | 37 | 0.130 |
Why?
|
| Viral Proteins | 1 | 2019 | 262 | 0.130 |
Why?
|
| Paracrine Communication | 1 | 2017 | 15 | 0.130 |
Why?
|
| Cells, Cultured | 4 | 2017 | 2151 | 0.130 |
Why?
|
| Muscle Cells | 1 | 2017 | 28 | 0.130 |
Why?
|
| ADAM Proteins | 2 | 2014 | 32 | 0.130 |
Why?
|
| Enzyme Stability | 2 | 2008 | 46 | 0.130 |
Why?
|
| beta-Glucans | 2 | 2008 | 56 | 0.130 |
Why?
|
| Respiratory Mucosa | 1 | 2017 | 53 | 0.130 |
Why?
|
| Epithelial Cells | 1 | 2019 | 389 | 0.130 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 2016 | 11 | 0.130 |
Why?
|
| Therapy, Soft Tissue | 1 | 2016 | 1 | 0.130 |
Why?
|
| Muscle Hypotonia | 1 | 2016 | 7 | 0.130 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2016 | 47 | 0.130 |
Why?
|
| Calcium Channels, L-Type | 1 | 2016 | 26 | 0.120 |
Why?
|
| Cell Separation | 1 | 2016 | 147 | 0.120 |
Why?
|
| Cartilage | 1 | 2016 | 35 | 0.120 |
Why?
|
| Doxorubicin | 1 | 2016 | 99 | 0.120 |
Why?
|
| Fecal Incontinence | 1 | 2016 | 30 | 0.120 |
Why?
|
| Molecular Sequence Data | 3 | 2009 | 1990 | 0.120 |
Why?
|
| Cellular Senescence | 1 | 2016 | 110 | 0.120 |
Why?
|
| Fingolimod Hydrochloride | 1 | 2015 | 2 | 0.120 |
Why?
|
| Temperature | 2 | 2008 | 307 | 0.120 |
Why?
|
| Kinetics | 2 | 2008 | 760 | 0.120 |
Why?
|
| Sphingosine | 1 | 2015 | 19 | 0.120 |
Why?
|
| Gliosis | 1 | 2015 | 28 | 0.120 |
Why?
|
| Lysophospholipids | 1 | 2015 | 26 | 0.120 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2013 | 91 | 0.120 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2015 | 8 | 0.120 |
Why?
|
| Injections, Intra-Articular | 1 | 2015 | 51 | 0.120 |
Why?
|
| Coculture Techniques | 1 | 2015 | 96 | 0.120 |
Why?
|
| Polyesters | 1 | 2015 | 47 | 0.110 |
Why?
|
| Organogenesis | 1 | 2015 | 39 | 0.110 |
Why?
|
| Fibroblasts | 1 | 2016 | 387 | 0.110 |
Why?
|
| Cell Proliferation | 3 | 2016 | 982 | 0.110 |
Why?
|
| Polyglycolic Acid | 1 | 2014 | 18 | 0.110 |
Why?
|
| Piperidines | 1 | 2014 | 63 | 0.110 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2013 | 17 | 0.110 |
Why?
|
| Aminoquinolines | 1 | 2013 | 16 | 0.110 |
Why?
|
| Arthritis, Experimental | 1 | 2013 | 29 | 0.110 |
Why?
|
| Lactic Acid | 1 | 2014 | 76 | 0.110 |
Why?
|
| Flavonoids | 1 | 2014 | 75 | 0.110 |
Why?
|
| Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2014 | 32 | 0.110 |
Why?
|
| Stem Cell Transplantation | 1 | 2013 | 79 | 0.100 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2015 | 147 | 0.100 |
Why?
|
| Astrocytes | 1 | 2014 | 119 | 0.100 |
Why?
|
| Neuropeptides | 1 | 2013 | 82 | 0.100 |
Why?
|
| Hyaluronic Acid | 1 | 2014 | 67 | 0.100 |
Why?
|
| Protease Inhibitors | 1 | 2014 | 102 | 0.100 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 176 | 0.100 |
Why?
|
| Pyrimidines | 1 | 2013 | 137 | 0.100 |
Why?
|
| Asthma | 1 | 2017 | 440 | 0.100 |
Why?
|
| Graft Survival | 1 | 2013 | 290 | 0.100 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2013 | 35 | 0.100 |
Why?
|
| Estradiol | 1 | 2013 | 257 | 0.100 |
Why?
|
| Escherichia coli | 2 | 2008 | 700 | 0.100 |
Why?
|
| Collagen | 1 | 2013 | 123 | 0.100 |
Why?
|
| Sphingomonas | 1 | 2012 | 1 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 614 | 0.090 |
Why?
|
| Models, Animal | 1 | 2013 | 236 | 0.090 |
Why?
|
| Cell Culture Techniques | 1 | 2013 | 182 | 0.090 |
Why?
|
| Collagen Type III | 1 | 2011 | 4 | 0.090 |
Why?
|
| Collagen Type I | 1 | 2011 | 41 | 0.090 |
Why?
|
| Phenanthrolines | 2 | 2024 | 10 | 0.090 |
Why?
|
| Adipose Tissue | 1 | 2013 | 295 | 0.090 |
Why?
|
| Transfection | 1 | 2013 | 692 | 0.090 |
Why?
|
| Female | 9 | 2024 | 32804 | 0.090 |
Why?
|
| Protein Isoforms | 1 | 2011 | 197 | 0.090 |
Why?
|
| Immunity, Innate | 1 | 2017 | 796 | 0.090 |
Why?
|
| Oxytocin | 2 | 2024 | 45 | 0.080 |
Why?
|
| Water Purification | 1 | 2009 | 6 | 0.080 |
Why?
|
| Apoptosis | 2 | 2013 | 1073 | 0.080 |
Why?
|
| Adhesins, Escherichia coli | 1 | 2009 | 3 | 0.080 |
Why?
|
| Lactococcus lactis | 1 | 2009 | 8 | 0.080 |
Why?
|
| Escherichia coli Vaccines | 1 | 2009 | 11 | 0.080 |
Why?
|
| Pregnancy | 3 | 2024 | 2333 | 0.080 |
Why?
|
| Enterotoxigenic Escherichia coli | 1 | 2009 | 22 | 0.080 |
Why?
|
| Iron | 1 | 2009 | 148 | 0.080 |
Why?
|
| Recovery of Function | 3 | 2015 | 287 | 0.070 |
Why?
|
| Osteoarthritis, Knee | 1 | 2013 | 385 | 0.070 |
Why?
|
| Escherichia coli Infections | 1 | 2009 | 87 | 0.070 |
Why?
|
| Nanoparticles | 1 | 2014 | 513 | 0.070 |
Why?
|
| Chlorine Compounds | 3 | 2013 | 3 | 0.070 |
Why?
|
| RNA, Messenger | 1 | 2013 | 1537 | 0.070 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 2179 | 0.070 |
Why?
|
| Artificial Gene Fusion | 1 | 2006 | 5 | 0.060 |
Why?
|
| Chromatography | 1 | 2006 | 16 | 0.060 |
Why?
|
| Bacteria | 1 | 2009 | 305 | 0.060 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2006 | 37 | 0.060 |
Why?
|
| Chondrogenesis | 2 | 2016 | 9 | 0.060 |
Why?
|
| Signal Recognition Particle | 1 | 2006 | 39 | 0.060 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2006 | 86 | 0.060 |
Why?
|
| Cloning, Molecular | 1 | 2006 | 382 | 0.060 |
Why?
|
| Protein Transport | 1 | 2006 | 400 | 0.060 |
Why?
|
| Gene Expression | 1 | 2008 | 839 | 0.060 |
Why?
|
| Enzyme Activation | 1 | 2005 | 380 | 0.060 |
Why?
|
| Structure-Activity Relationship | 1 | 2005 | 371 | 0.050 |
Why?
|
| Endothelin-1 | 1 | 2024 | 7 | 0.050 |
Why?
|
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 2024 | 7 | 0.050 |
Why?
|
| Dinoprost | 1 | 2024 | 19 | 0.050 |
Why?
|
| Delayed-Action Preparations | 2 | 2015 | 114 | 0.050 |
Why?
|
| Protein Folding | 1 | 2004 | 267 | 0.050 |
Why?
|
| Chloramines | 2 | 2013 | 2 | 0.050 |
Why?
|
| Oxides | 2 | 2013 | 37 | 0.050 |
Why?
|
| Protein Conformation | 1 | 2005 | 779 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2016 | 1274 | 0.050 |
Why?
|
| Cell Line | 2 | 2017 | 2036 | 0.050 |
Why?
|
| Transcription, Genetic | 1 | 2004 | 878 | 0.040 |
Why?
|
| Litter Size | 1 | 2019 | 10 | 0.040 |
Why?
|
| Potassium Chloride | 1 | 2019 | 15 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2024 | 1356 | 0.040 |
Why?
|
| A549 Cells | 1 | 2019 | 39 | 0.040 |
Why?
|
| Urinary Incontinence, Stress | 1 | 2019 | 25 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2019 | 207 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2019 | 93 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2019 | 542 | 0.040 |
Why?
|
| Male | 5 | 2017 | 29832 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2019 | 204 | 0.030 |
Why?
|
| Electrophysiological Phenomena | 1 | 2017 | 21 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2019 | 534 | 0.030 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2017 | 16 | 0.030 |
Why?
|
| Transducin | 1 | 2017 | 7 | 0.030 |
Why?
|
| Magnesium Sulfate | 1 | 2017 | 9 | 0.030 |
Why?
|
| Dermis | 1 | 2017 | 18 | 0.030 |
Why?
|
| Guinea Pigs | 1 | 2017 | 84 | 0.030 |
Why?
|
| Skin Physiological Phenomena | 1 | 2017 | 16 | 0.030 |
Why?
|
| Albuterol | 1 | 2017 | 24 | 0.030 |
Why?
|
| Epidermis | 1 | 2017 | 36 | 0.030 |
Why?
|
| Chloroquine | 1 | 2017 | 61 | 0.030 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2017 | 29 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2019 | 619 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2017 | 104 | 0.030 |
Why?
|
| Niflumic Acid | 1 | 2016 | 3 | 0.030 |
Why?
|
| Bethanechol | 1 | 2016 | 4 | 0.030 |
Why?
|
| Nifedipine | 1 | 2016 | 19 | 0.030 |
Why?
|
| Defecation | 1 | 2016 | 17 | 0.030 |
Why?
|
| Digoxin | 1 | 2016 | 22 | 0.030 |
Why?
|
| Cellular Microenvironment | 1 | 2016 | 21 | 0.030 |
Why?
|
| Patch-Clamp Techniques | 1 | 2016 | 130 | 0.030 |
Why?
|
| Rheumatic Heart Disease | 1 | 2016 | 22 | 0.030 |
Why?
|
| Biocompatible Materials | 1 | 2017 | 150 | 0.030 |
Why?
|
| Membrane Potentials | 1 | 2016 | 141 | 0.030 |
Why?
|
| Administration, Topical | 1 | 2015 | 51 | 0.030 |
Why?
|
| Membranes, Artificial | 1 | 2015 | 45 | 0.030 |
Why?
|
| Tendinopathy | 1 | 2015 | 10 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2015 | 89 | 0.030 |
Why?
|
| SOX9 Transcription Factor | 1 | 2014 | 7 | 0.030 |
Why?
|
| DNA Damage | 1 | 2016 | 280 | 0.030 |
Why?
|
| Early Growth Response Protein 2 | 1 | 2014 | 8 | 0.030 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2014 | 15 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2014 | 40 | 0.030 |
Why?
|
| Skin | 1 | 2017 | 372 | 0.030 |
Why?
|
| Surface Properties | 1 | 2015 | 278 | 0.030 |
Why?
|
| Eyelids | 1 | 2013 | 8 | 0.030 |
Why?
|
| ADAMTS5 Protein | 1 | 2013 | 1 | 0.030 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2013 | 7 | 0.030 |
Why?
|
| Aggrecans | 1 | 2014 | 8 | 0.030 |
Why?
|
| Hypertrophy | 1 | 2013 | 30 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2014 | 111 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2013 | 77 | 0.030 |
Why?
|
| Fibroblast Growth Factors | 1 | 2014 | 72 | 0.030 |
Why?
|
| Microspheres | 1 | 2013 | 56 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2014 | 115 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2015 | 5660 | 0.030 |
Why?
|
| Phenotype | 1 | 2017 | 1199 | 0.030 |
Why?
|
| Transplantation, Heterologous | 1 | 2013 | 229 | 0.030 |
Why?
|
| Athletic Injuries | 1 | 2014 | 83 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 377 | 0.030 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2013 | 142 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2013 | 151 | 0.020 |
Why?
|
| Proteolysis | 1 | 2014 | 145 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2014 | 264 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2014 | 230 | 0.020 |
Why?
|
| Methylobacterium | 1 | 2012 | 1 | 0.020 |
Why?
|
| Biomarkers | 1 | 2017 | 1397 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2014 | 393 | 0.020 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2013 | 265 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2014 | 325 | 0.020 |
Why?
|
| Corrosion | 1 | 2009 | 3 | 0.020 |
Why?
|
| Bioreactors | 1 | 2009 | 36 | 0.020 |
Why?
|
| Mice, Inbred ICR | 1 | 2009 | 32 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 3388 | 0.020 |
Why?
|
| Neurons | 1 | 2014 | 922 | 0.020 |
Why?
|
| Antibodies, Bacterial | 1 | 2009 | 181 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2009 | 369 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2009 | 581 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2009 | 265 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2009 | 413 | 0.020 |
Why?
|
| Inflammation | 1 | 2014 | 1145 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2009 | 459 | 0.020 |
Why?
|
| Aged | 1 | 2016 | 14396 | 0.010 |
Why?
|
| Middle Aged | 1 | 2016 | 17557 | 0.010 |
Why?
|